title: [Non-muscle invasive transitional cell carcinoma of the bladder. New developments in diagnostics and therapy].
abstract: Due to the high incidence and recurrence rate non-muscle invasive bladder cancer (NMIBC) has a relevant impact. Raman spectroscopy and optical coherence tomography represent innovative diagnostic tools. Urine markers still play a minor role in the diagnostics of NMIBC. New therapeutic options are thermochemotherapy and mitomycin-C electromotive drug administration (MMC-EMDA) as well as gemcitabine and apaziquone for intravesical administration.
authors.affiliation: Klinik und Poliklinik für Urologie, UK-SH Campus Lübeck, Ratzeburgerallee 160, 23568 Lübeck. martin.sommerauer@uk-sh.de
authors.forename: M
authors.initials: M
authors.lastname: Sommerauer
authors.forename: D
authors.initials: D
authors.lastname: Jocham
authors.forename: J M
authors.initials: JM
authors.lastname: Laturnus
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015415:Biomarkers / Q000652:urine; D002295:Carcinoma, Transitional Cell / Q000175:diagnosis* / Q000628:therapy* / Q000652:urine; D005544:Forecasting; D006801:Humans; D006979:Hyperthermia, Induced / Q000639:trends*; D009130:Muscle, Smooth / Q000473:pathology; D009361:Neoplasm Invasiveness; D013059:Spectrum Analysis, Raman / Q000379:methods; D041623:Tomography, Optical Coherence / Q000639:trends*; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis* / Q000628:therapy* / Q000652:urine
chemical_list: D000970:Antineoplastic Agents; D015415:Biomarkers